On October 24, CPhI Worldwide 2017 was grandly opened in Frankfurt, Germany. BOAI NKY Pharmaceuticals Ltd., a subsidiary of NKY Medical Group (Stock Code: 300109) showcased with a new gesture in the global pharmaceutical industry event. There is an international marketing team consists of 11 members (including 5 overseas employees in different countries) to participate in this event. With the new market strategy, NKY introduced the excellent technology advanced products to the global customers.
With its emphasis on product development, continuous improvement of management level and product quality, NKY aims to be an internationally renowned manufacturer and solution provider of pharmaceutical excipients and functional polymers by striving to improve its clean production and sustainable development.
Before the exhibition, Vice Chairman of NKY Medical Group Mr. Wang Jianqiang organized the international sales team to conduct a detailed discussion and analysis on the market strategy and formulated a detailed international market strategy to plan the long-term sustainable development of NKY Pharmaceuticals. NKY PVP products and OraRez products have received widespread attention at the exhibition, while promoting the new pharmaceutical excipients products of cooperative partner. Prior to this exhibition, the NKY German subsidiary has added new marketing forces, which will play a key role in the future development of European business.